Bill

Bill > A4052


NJ A4052

NJ A4052
Establishes three-year sickle cell disease pilot program; appropriates $10,200,000.


summary

Introduced
05/19/2022
In Committee
11/30/2023
Crossed Over
06/30/2023
Passed
12/21/2023
Dead
Signed/Enacted/Adopted
01/08/2024

Introduced Session

2022-2023 Regular Session

Bill Summary

Establishes three-year sickle cell disease pilot program; appropriates $10,200,000.

AI Summary

This bill establishes a three-year sickle cell disease pilot program in New Jersey. The program will provide funding to selected federally qualified health centers to develop and implement comprehensive sickle cell disease treatment programs and services. The key goals of the program are to: link outpatient and inpatient sickle cell disease care, provide coordinated and comprehensive medical, behavioral, and social services to individuals with sickle cell disease, promote education and awareness, build a state medical workforce knowledgeable about sickle cell disease, and collect data to monitor the incidence, prevalence, and costs of sickle cell disease in the state. The bill appropriates $10.2 million from the General Fund to the Department of Health to support the pilot program.

Committee Categories

Budget and Finance, Health and Social Services

Sponsors (26)

Last Action

Approved P.L.2023, c.242. (on 01/08/2024)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...